- •Ticket 1
- •3. Antihypertensive agents affecting water-salt exchange. Classification. Mechanism of action. Side effects. Contraindications. Comparative evaluation of preparations.
- •4. Antiseptics of aromatic and aliphatic series. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •Ticket 2.
- •Distribution of drugs in the body. Biotransformation of drugs in the body and ways of their extraction. The concept of bioavailability.
- •2. Binding, engraving, adsorbating, irritating substances. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •1. Suction of medicinal substances from the place of administration. Transportation of medicinal substances through cellular membranes.
- •3. Drugs stimulating fibrinolysis. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative assessment.
- •4. Halogen-containing antiseptics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •Ticket 3.
- •2.Tranquilizers. Classification. Action mechanism. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •1) Means used for diagnostic purposes
- •Indications: used in case of weakened but preserved gastric function
- •2. Antiseptics - compounds of metals. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •Season 4
- •Gink derivatives
- •Indications for use:
- •I Inhibition of the activity of the thromboxane system
- •III Drugs that inhibit the binding of fibrinogen to platelet glycoprotein receptors
- •Season 5
- •Indications:
- •Season 6
- •Indications:
- •3) Preparations for topical use:
- •4) Combined preparations of sulfonamides with trimethoprim
- •Ticket 7
- •1. Development of pharmacology in Russia. Pharmokopeia, its legal significance. Prescription - Jur. Document.
- •2. Counterarkinsonian funds. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Rational combination and combined drugs for the treatment of hypertension. Explain the rationality of the application.
- •Ticket 8
- •3. Anticoagulants. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 9
- •3. Drugs used to treat bronchial asthma. Classification. Mechanisms of action. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 10
- •1. Definition of pharmacology as a science, its tasks, place among other medical and biological sciences. Scientific substantiation of the need for animal experiments.
- •Ticket 11
- •1. Dependence of the effect on the dose (concentration) of the active substance. The breadth of the therapeutic action. The value of the choice of dosage forms and methods of drug administration.
- •2. Antipsychotics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs. The concept of neuroleptanalgesia
- •3. Cardiac glycosides. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antifungal drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •I. Means used in the treatment of diseases caused by pathogenic fungi:
- •II. Drugs used in the treatment of diseases caused by opportunistic fungi (for example, with candidiasis):
- •Ticket number 12
- •Types of action of medicinal substances
- •2. Alpha and alpha, beta adrenomimetic substances. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 13
- •1. Pharmacological work of domestic physiologists and clinicians (im Sechenov, ip Pavlov, sp Botkin, ni Pirogov)
- •3. Preparations of sex hormones and their antagonists. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for use:
- •Indications for use:
- •4. Antimalarial drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications:
- •Ticket 14
- •1. Features of the action and dosage of medicinal substances for various routes of administration.
- •2. Local anesthetic substances. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for the use of local anesthetics:
- •3. Preparations of fat-soluble vitamins. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Vitamin a preparations are indicated:
- •Ticket 15
- •2. Nootropics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for use:
- •3. Antihypertensive drugs of peripheral neurotropic action. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Anti-tuberculosis drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 16
- •1. Types of action of medicinal substances.
- •2. Sympatholytic remedies. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antiviral agents. Classification. Mechanism of action. The nature of the action. Spectrum of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 17.
- •1. Side and toxic effects of medicinal substances. Allergic and non-allergic side effects. Toxicity. Teratogenicity. Embryotoxicity. Carcinogenicity. Idiosyncrasy.
- •2. Analeptics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Choleretic drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Anti-spirochete drugs. Classification. Mechanism of action. Indications for use. Side effects. Comparative characteristics.
- •Ticket 18.
- •1. Pharmacological work of domestic physiologists and clinicians (im Sechenov, ip Pavlov, sp Botkin, ni Pirogov)
- •2. Beta-adrenergic agonists. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Antacids. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative characteristics.
- •Ticket 19
- •1. The combined effect of drugs. Synergy. Antagonism. Antidote.
- •2.Sleeping drugs. Classification by chemical structure. Mechanism of action. Side effects. Contraindications Comparative evaluation. Possibilities for the development of addiction.
- •3. Class II antiarrhythmic drugs (Beta-blockers). Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Complications arising from the use of antibiotics, measures for their prevention.
- •Ticket 20
- •1. Changes in the body's reactions to medicinal substances during their repeated administration. The concept of addiction, drug dependence, tachyphylaxis, sensitization. Cumulation of drugs.
- •2. Ganglion blocking agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of the drug.
- •3. Means that reduce the secretion of gastric glands. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of drugs.
- •Ticket 21
- •1. Basic principles of first aid for acute drug poisoning.
- •2. Alpha-adrenergic blocking agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of drugs.
- •3.Calcium channel blockers for the treatment of coronary heart disease. Classification Mechanism of action Side effects Contraindications Comparative assessment of drugs
- •Ticket number 22
- •3). Leukopoiesis stimulants. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket number 23
- •2). Narcotic (opioid) analgesics. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs. Antagonists of narcotic analgesics.
- •1. Plant origin
- •2. Synthetic morphine substitutes
- •3). Gastroprotectors. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications:
- •Ticket number 24
- •III. Agents that activate the gabAergic system
- •IV. Agents that lower the activity of the glutamatergic system
- •3). Diuretics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •2). Antiepileptic drugs. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for use:
- •Ticket 25
- •1. Side and toxic effects of medicinal substances. Allergic and non-allergic side effects. Toxicity. Teratogenicity. Embryotoxicity. Carcinogenicity. Idiosyncrasy.
- •3. Antitussives. Classification Mechanism of action Indications for use Side effects Contraindications Comparative assessment of drugs
- •Ticket 26
- •2. Sedatives. Classification. Mechanism of action. Indications for use Side effects Contraindications Comparative evaluation of drugs.
- •3. Anti-inflammatory drugs of steroid structure. Classification Mechanism of action Indications for use Side effects Contraindications Comparative assessment of drugs
- •Ticket 27
- •1. Basic principles and methods of testing new medicinal substances. The concepts of "placebo" and "blind" control. The ethical side of prescribing a placebo.
- •3. Means that help stop bleeding (hemostatics). Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of drugs.
- •3) Preparations for topical use:
- •4) Combined preparations of sulfonamides with trimethoprim
- •Ticket number 28
- •1. Combined action of medicinal substances. Synergy. Antagonism. Antidote.
- •2. Psychostimulants. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket number 29
- •1. Dependence of the effect on the dose (concentration) of the active substance. The breadth of the therapeutic action. The value of the choice of dosage forms and methods of drug administration.
- •2. Alpha-adrenergic blocking agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Drugs affecting immunity. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antifungal drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 30
- •2. Sympatholytic agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Preparations of pancreatic hormones. Synthetic hypoglycemic agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Anti-spirochete drugs. Classification. Mechanism of action. Indications for use. Side effects. Comparative characteristics.
- •Ticket 31
- •1. Distribution of medicinal substances in the body. Biotransformation of medicinal substances in the body and ways of their excretion. Concept and bioavailability.
- •2. Narcotic (opioid) analgesics. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs. Antagonists of narcotic analgesics.
- •3. Laxatives. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Complications arising from the use of antibiotics, measures for their prevention.
- •Ticket 32.
- •3. Stimulants of respiration. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 33.
- •1. Features of the action and dosage of medicinal substances for various routes of administration.
- •2. Antipsychotics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs. The concept of neuroleptanalgesia.
- •3. Class IV antiarrhythmics (calcium channel blockers). Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 34
- •1) Development of pharmacology in Russia. Pharmacology and its legal significance. Treating the recipe as a legal document.
- •3... Antihypertensive drugs that affect the renin-angiotensin system. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antiviral agents. Classification. Mechanism of action. The nature of the action. Indications for use. Side effects. Contraindications Comparative characteristics of drugs.
- •Ticket 35
- •6. Homeopathy, basic principles. Evaluation of the homeopathic treatment method.
- •2. Nootropics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for use:
- •3) Drugs used in myocardial infarction. Classification. Mechanism of action. Side effects. Contraindications Indications for use. Comparative characteristics
- •Ticket 36
- •2. Local anesthetic substances. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for the use of local anesthetics:
- •3) Anti-atherosclerotic drugs. Classification, Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation.
- •Indications:
- •Ticket 37
- •Basic principles (mechanisms) of action of medicinal substances. Their interaction with receptors.
- •Antihypertensive drugs of central neurotropic action. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •1. Basic principles (mechanisms) of action of medicinal substances. Their interaction with receptors.
- •3. Antihypertensive drugs of central neurotropic action. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 38
- •4. Antiblastic substances. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 39
- •4. Differences between chemotherapeutic agents and antiseptics. Basic principles of ht. Criteria for evaluation.
- •Ticket 40.
- •3. Preparations of water-soluble vitamins. Classification. Mechanism of action. Indications. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antihelminthic agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 41.
- •1. Principles of drug discovery. Ways of synthesis of pharmacological substances. Obtaining preparations from plant and animal raw materials.
- •Inhalation : volatile liquids: ether, fluorothane, sevoflurane, isoflurane, methoxyflurane
- •3. Class III antiarrhythmic drugs (potassium channel blockers). Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications:
- •4. Dyes. Detergents. Oxidizing agents. Acids and alkalis.
- •Ticket 42
- •1. Pharmacological work of domestic physiologists and clinicians (im Sechenov, ip Pavlov, sp Botkin, ni Pirogov).
- •2. Beta-adrenergic agonists. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Vomiting and antiemetic. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 43
- •1. The combined action of medicinal substances. Synergy. Antagonism. Antidote.
- •2. Antiparkinsonian drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Enzyme preparations. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications:
- •Ticket 44.
- •The dependence of the effect on the dose (concentration) of the active substance. The breadth of the therapeutic action. The value of the choice of dosage forms and methods of drug administration.
- •2. Curariform funds. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Means that affect appetite. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •1.Media that stimulate appetite:
- •Ticket 45.
- •1. Types of action of medicinal substances.
- •2. Antidepressants. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Gink derivatives
- •Indications for use:
- •4. Anti-tuberculosis drugs. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 46
- •Ticket 47
- •3. Means that increase the tone and contraction of the myometrium. Classification. Mechanism of action. Indications for use. Contraindications Comparative evaluation of drugs.
- •4. Halogen-containing antiseptics. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of preparations.
- •Season 48
- •Distribution of drugs in the body. Biotransformation of drugs in the body and ways of their extraction. The concept of bioavailability.
- •2). Antiepileptic drugs. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •III. Agents that activate the gabAergic system
- •IV. Agents that lower the activity of the glutamatergic system
- •3. Antiadrenergic drugs for the treatment of coronary heart disease. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •4. Antiseptics - metal compounds. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •Inhalation : volatile liquids: ether, fluorothane, sevoflurane, isoflurane, methoxyflurane
- •3. Blockers of calcium channels for the treatment of hypertension. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
- •Ticket 50
- •1. Side and toxic effects of medicinal substances. Allergic and non-allergic side effects. Toxicity. Teratogenicity. Embryotoxicity. Carcinogenicity. Idiosyncrasy.
- •2. Ganglion blocking agents. Classification. Mechanism of action. Indications for use. Side effects. Contraindications. Comparative evaluation of the drug.
- •3. Preparations of pituitary hormones. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •Indications for use
- •Indications for use
- •Indications for use:
- •Ticket 51
- •1. Features of the action and dosage of medicinal substances for various routes of administration.
- •2. Alpha and alpha, beta adrenomimetic substances. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
- •3. Glycosidic intoxication. Preventive and emergency measures.
- •Ticket 52
- •3. Antihypertensive drugs of myotropic action. Classification. Mechanism of action. Side effects. Contraindications Comparative evaluation of drugs.
3. Preparations of pituitary hormones. Classification. Mechanism of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
Share pituitary gland |
Hormone |
Hormone preparations |
Front |
Adrenocorticotropic hormone (ACTH) |
Corticotropin Tetracosactide |
Growth hormone (growth hormone, STH, somatotropin) |
Somatotropin Somatrem |
|
Thyroid stimulating hormone (thyrotropin, TSH) |
Tyrotropin |
|
Follicle-stimulating hormone (follitropin, FSH) |
Menotropins (menopausal gonadotropin, pergonal, menogon) Urofolitropin Folitropin alpha Folitropin beta |
|
Luteinizing hormone (lutotropin, LH) |
Chorionic gonadotropin Lutropin alpha |
|
Lactotropic hormone (prolactin, LT) |
Lactin |
|
Average |
Melanotropic hormone (melatropin, melanocyte-stimulating) |
Intermedin |
Back |
Oxytocin |
Oxytocin |
Vasopressin (antidiuretic hormone) |
Vasopressin, Desmopressin Terlipressin Pituitrin Adiurecrin |
Corticotropin - a diagnostic tool for assessing the reserves of the adrenal cortex in primary adrenal insufficiency or in case of its hypofunction against the background of prolonged use of glucocorticoids.
Tetracosactide (synacthen depot, cozintropin)
has less immunogenicity
less likely to cause allergic reactions
lasts longer and can be applied once a day.
Indications for use
- prevention of complications of long-term use of GC;
- in the complex therapy of connective tissue diseases, allergic diseases, dermatoses, ulcerative colitis.
Genetically engineered somatotropin analogs - sayen, humatrop, biosome, genotropin, zomactone, norditropin
Indications for use:
pituitary dwarfism;
growth disorders in children with chronic renal failure;
gonadal dysgenesis (Shereshevsky-Turner syndrome)
Menotropins (menopausal gonadotropin, pergonal, menogon, humegon) - FSH and LH in a 1: 1 ratio (75 IU each).
Urofolitropin - FSH and a small amount of LH.
Follitropin alpha (gonal-F) and follitropin beta (puregon) - recombinant FSH.
Indications for use
Among women - anovulatory infertility due to hypothalamic-pituitary disorders during reproductive procedures.
in men - violation of spermatogenesis, hypothalamic-pituitary hypogonadism.
Oxytocin
Desaminooxytocin (Sandopart, Demoxytocin)
(tablet form, buccal, does not increase blood pressure)
Hyphotocin (pituitrin M)
Indications for use:
stimulation of labor in post-term pregnancy, premature discharge of amniotic fluid, weakness of labor in the second stage of labor (expulsion of the fetus);
treatment and prevention of atonic uterine bleeding after abortion, in the early postpartum period;
to accelerate the involution of the uterus;
hypolactation in the postpartum period.
4. Antibiotics from the group of macrolides and aminoglycosides. Classification. Mechanism of action. The nature of the action. Spectrum of action. Indications for use. Side effects. Contraindications Comparative evaluation of drugs.
Macrolides are low-toxic agents for oral administration for infections caused by G + bacteria and intracellular microorganisms. There are 3 generations of macrolides:
Erythromycin, oleandomycin
Spiramycin, dirithromycin
Azithromycin (sumamed)
Mechanism of action of AB - inhibit microbial cell protein synthesis
Origin classification:
Natural - erythromycin, oleandomycin, spiromycin
Prodrugs - oleandomycin-troleandromycin esters
Semi-synthetic - azithromycin
Macrolides, depending on the type of microorganism and dose, can have a bracteriostatic or bactericidal effect. Spectrum of action: staphylococcus, streptococcus, pneumococcus, meningococcus, gonococcus, corynebacterium diphtheria, clostridium gas gangrene
Macrolides are prescribed orally and some intravenously (erythromycin).
Macrolides:
- have a mucoregulatory effect
- weaken the inflammatory reaction as a result of inhibition of the synthesis of PG, LTE and IL
- about immunomodulatory properties
Indications for use: - infections of the upper and lower respiratory tract - whooping cough and its prevention - diphtheria - infections of the skin and soft tissues - other functions of the oral cavity - trachoma - sexually transmitted infections |
Side-by-side: - nausea, vomiting - cramping abdominal pain - fever - jaundice - with i / v - thrombophlebitis, Hearing impairment |
Contraindications: - hypersensitivity - pregnancy - breast-feeding |
There are 3 generations of aminoglycoside antibiotics (classification):
- I generation - streptomycin, kanamycin, neomycin (used only for local action);
- II generation - gentamicin, tobramycin, amikacin;
- III generation - netilmicin (has less oto- and vestibulotoxicity).
Streptomycin and kanamycin suppress mycobacterium tuberculosis, streptomycin is active against brucella, the causative agents of plague and tularemia. The most sensitive to neomycin are Escherichia coli, Klebsiella, Enterococcus, Proteus and Enterobacter species. Antibiotics of the II - III generation are toxic for E. coli, Klebsiella, Serration, Pseudomonas aeruginosa, Proteus species, Enterobacter and Acinetobacter. All aminoglycosides inhibit 90% of Staphylococcus aureus strains. Resistance to aminoglycosides is characteristic of anaerobic bacteria, hemolytic streptococci, and pneumococci.
The bactericidal effect of aminoglycosides is due to the formation of abnormal proteins and the detergent effect on the lipoprotein cytoplasmic membrane of microorganisms.
Antibiotics of the β-lactam group, inhibiting the synthesis of the cell wall, potentiate the antimicrobial effect of aminoglycosides. Levomycetin, blocking transport systems in the cytoplasmic membrane, weakens their action.
When these antibiotics are taken by mouth, dyspeptic disorders are common. Anaphylactic shock is mainly caused by streptomycin sulfate, which in this respect is in second place after penicillin preparations.
Aminoglycosides can disturb hearing, balance (in 10 - 25% of patients), kidney function, and cause neuromuscular blockade. At the beginning of aminoglycoside therapy, tinnitus appears.
Aminoglycosides are contraindicated in hypersensitivity, botulism, myasthenia gravis, Parkinson's disease, drug parkinsonism, hearing and balance disorders, severe kidney disease. Their use during pregnancy is allowed only for health reasons. During treatment, breastfeeding is stopped.
Indications:Tuberculosis-streptomycin, kanamycin; plague streptomycin; tularemia-streptomycin, gentamicin, brucellosis-streptomycin
purulent-septic diseases - sepsis, peritonitis, meningitis, abscess;
postoperative infectious complications;
kidney infections - pyelonephritis, respiratory tract - pneumonia, lung abscess;
infective endocarditis;
